209 related articles for article (PubMed ID: 32344707)
1. The Prognostic Value of the Detection of Microbial Translocation in the Blood of Colorectal Cancer Patients.
Messaritakis I; Vogiatzoglou K; Tsantaki K; Ntretaki A; Sfakianaki M; Koulouridi A; Tsiaoussis J; Mavroudis D; Souglakos J
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32344707
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Microbial Translocation,
Messaritakis I; Koulouridi A; Boukla E; Sfakianaki M; Vogiatzoglou K; Karagianni M; Gouvas N; Tsiaoussis J; Xynos E; Athanasakis E; Mavroudis D; Tzardi M; Souglakos J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139567
[TBL] [Abstract][Full Text] [Related]
3. The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk.
Messaritakis I; Koulouridi A; Sfakianaki M; Vogiatzoglou K; Gouvas N; Athanasakis E; Tsiaoussis J; Xynos E; Mavroudis D; Tzardi M; Souglakos J
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471257
[TBL] [Abstract][Full Text] [Related]
4. Detection of microbial DNA in the blood of surgical patients for diagnosing bacterial translocation.
Ono S; Tsujimoto H; Yamauchi A; Hiraki S; Takayama E; Mochizuki H
World J Surg; 2005 Apr; 29(4):535-9. PubMed ID: 15776295
[TBL] [Abstract][Full Text] [Related]
5. Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis.
Messaritakis I; Koulouris A; Boukla E; Vogiatzoglou K; Lagkouvardos I; Intze E; Sfakianaki M; Chondrozoumaki M; Karagianni M; Athanasakis E; Xynos E; Tsiaoussis J; Christodoulakis M; Flamourakis ME; Tsagkataki ES; Giannikaki L; Chliara E; Mavroudis D; Tzardi M; Souglakos J
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792001
[TBL] [Abstract][Full Text] [Related]
6. Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment.
Koulouridi A; Messaritakis I; Theodorakis E; Chondrozoumaki M; Sfakianaki M; Gouvas N; Tsiaoussis J; Mavroudis D; Tzardi M; Souglakos J
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298766
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
Messaritakis I; Stogiannitsi M; Koulouridi A; Sfakianaki M; Voutsina A; Sotiriou A; Athanasakis E; Xynos E; Mavroudis D; Tzardi M; Souglakos J
PLoS One; 2018; 13(6):e0197327. PubMed ID: 29883450
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota and its association with colon cancer and red/processed meat consumption.
Abu-Ghazaleh N; Chua WJ; Gopalan V
J Gastroenterol Hepatol; 2021 Jan; 36(1):75-88. PubMed ID: 32198788
[TBL] [Abstract][Full Text] [Related]
11. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
12. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
13. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Receptor Protects Against Dysbiosis and Tumorigenesis via the JAK/STAT Pathway in Intestine.
Zhang YG; Lu R; Wu S; Chatterjee I; Zhou D; Xia Y; Sun J
Cell Mol Gastroenterol Hepatol; 2020; 10(4):729-746. PubMed ID: 32497792
[TBL] [Abstract][Full Text] [Related]
15. Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis.
Coleman OI; Lobner EM; Bierwirth S; Sorbie A; Waldschmitt N; Rath E; Berger E; Lagkouvardos I; Clavel T; McCoy KD; Weber A; Heikenwalder M; Janssen KP; Haller D
Gastroenterology; 2018 Nov; 155(5):1539-1552.e12. PubMed ID: 30063920
[TBL] [Abstract][Full Text] [Related]
16. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer.
Zgaga L; Theodoratou E; Farrington SM; Din FV; Ooi LY; Glodzik D; Johnston S; Tenesa A; Campbell H; Dunlop MG
J Clin Oncol; 2014 Aug; 32(23):2430-9. PubMed ID: 25002714
[TBL] [Abstract][Full Text] [Related]
17. Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population.
Alkhayal KA; Awadalia ZH; Vaali-Mohammed MA; Al Obeed OA; Al Wesaimer A; Halwani R; Zubaidi AM; Khan Z; Abdulla MH
PLoS One; 2016; 11(6):e0155236. PubMed ID: 27309378
[TBL] [Abstract][Full Text] [Related]
18. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
19. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
20. Decreased vitamin D receptor protein expression is associated with progression and poor prognosis of colorectal cancer patients.
Shi Q; Han XP; Yu J; Peng H; Chen YZ; Li F; Cui XB
Int J Clin Exp Pathol; 2020; 13(4):746-755. PubMed ID: 32355523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
